Delivery Order SPE2DE21D7020-SPE2D625F2URK
- Not listed
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $45,000 fixed-price delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, effective through August 14, 2025. This delivery order, which includes economic price adjustment provisions, represents Boston Scientific's continued supply of advanced cardiac intervention technologies to the federal healthcare system. The award was made without a set-aside designation, allowing Boston Scientific to...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order valued at $92,950 to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This delivery order, with a fixed-price contract structure that includes economic price adjustment provisions, was awarded on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This award represents a continuation...
- The Defense Health Agency's Medical Supply Chain issued a delivery order valued at $92,950 on August 11, 2025, to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 18, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract utilizes no set-aside designation, allowing the award to be made through open competition. As a...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp valued at $16,900 for the FARAPULSE Pulsed Field Ablation System. The contract, issued on August 18, 2025, with an ultimate completion date of August 25, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. Performance will be conducted at Boston Scientific's Marlborough, Massachusetts facility, where the company manufactures advanced...
- Boston Scientific Corp was awarded a delivery order valued at $92,950.00 for the FARAPULSE Pulsed Field Ablation System on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract is fixed-price with economic price adjustment and carries no set-aside designation. The award was funded through the Defense Health Agency's Medical Supply Chain and will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The FARAPULSE system represents a...
- Boston Scientific Corp was awarded a $49.8K fixed-price delivery order with economic price adjustment on July 11, 2025, for the FARAPULSE Pulsed Field Ablation System. The contract is funded through the Defense Health Agency's Medical Supply Chain program and extends through July 18, 2025. The system will be delivered to Marlborough, Massachusetts, where Boston Scientific maintains its primary operations. This delivery order is not set aside for any specific business classification and...
- The Defense Health Agency's Medical Supply Chain awarded a $67.6K delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts,...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Boston Scientific Corp, doing business as Boston Scientific. The $69,800 fixed-price delivery order is for the FARAPULSE Pulsed Field Ablation System, which is a medical device used in cardiovascular procedures. The contract has an ultimate completion date of May 20, 2024. Boston Scientific is a leading manufacturer of innovative medical technologies, including implantable...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $156,223.68, is for the delivery of a FARAPULSE Pulsed Field Ablation System, a medical device used for cardiac procedures. The contract has a performance period through March 18, 2025 and is a Delivery Order under a fixed-price with economic price adjustment contract type. The...
- The U.S. Defense Health Agency (DHA) awarded a $8,450.00 fixed-price with economic price adjustment contract to Boston Scientific Corporation, doing business as Boston Scientific, to deliver a Farapulse Pulsed Field Ablation System. This delivery order, with a completion date of July 26, 2024, was issued under a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle. Boston Scientific has a history of supplying medical devices and services to federal healthcare agencies such as...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2URKDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, valued at approximately $52K with a fixed-price contract that includes economic price adjustment provisions. The delivery order was issued on September 8, 2025, with an ultimate completion date of September 15, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. No small business set-aside was utilized for this procurement. Boston Scientific, a global medical technology leader headquartered in Massachusetts, serves as a prime contractor across multiple federal healthcare agencies, including the Department of Veterans Affairs and the Defense Health Agency. The company specializes in cardiovascular, interventional, and diagnostic medical devices, and this delivery order for the FARAPULSE system—an advanced cardiac ablation technology—aligns with Boston Scientific's established portfolio of cardiac intervention tools supplied to federal healthcare systems. The company maintains significant federal contract vehicles with the Defense Health Agency, positioning it as a critical supplier of specialized medical technologies to support federal military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.0k | 9/8/25 |